Made Scientific Partners with Hemogenyx Pharmaceuticals to Advance Revolutionary CAR-T Cell Therapy for Acute Myeloid Leukemia#USA#CAR-T_therapy#Princeton,_NJ#Made_Scientific#Hemogenyx_Pharmaceuticals
Made Scientific Partners with Hemogenyx Pharmaceuticals to Advance Revolutionary CAR-T Cell Therapy for Acute Myeloid Leukemia
Made Scientific and Hemogenyx Pharmaceuticals have joined forces to enhance HG-CT-1, an innovative CAR-T therapy aimed at treating acute myeloid leukemia, focusing on both adults and potentially pediatric patients.
third-news.com
September 8, 2025 at 2:09 PM
Made Scientific Partners with Hemogenyx Pharmaceuticals to Advance Revolutionary CAR-T Cell Therapy for Acute Myeloid Leukemia#USA#CAR-T_therapy#Princeton,_NJ#Made_Scientific#Hemogenyx_Pharmaceuticals